N/A
N=16
Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management
Colon Cancer · Rectal Cancer
Bottom Line
View on ClinicalTrials.gov: NCT02460822 ↗Enrolled (actual)
16
Serious AEs
0.0%
Results posted
May 2017
Primary outcome: Primary: Patient Retention and Engagement With the MyChemoCare Application — 15; 12 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- MyChemoCare iPad application (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Michigan
- Primary completion
- Nov 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Retention and Engagement With the MyChemoCare Application |
15; 12 | — |
| PRIMARY Patient Satisfaction and Usability of the MyChemoCare Application |
3.95 | — |
| SECONDARY Physician Use of the Study Feedback Mechanism |
16 | — |
| SECONDARY Increased Mastery of Cancer and Chemotherapy Symptoms |
9 | — |
| SECONDARY Symptom Burden Reduction |
9 | — |
| SECONDARY Improved Quality of Life |
9 | — |
Summary
This research project addresses critical gaps in cancer symptom management through the creation of a mobile chemotherapy symptom management application. This application will assess for the presence and severity of common chemotherapy side-effects and provide personally tailored symptom-related video and narratives to enhance self-management of cancer and treatment-related symptoms. This study will examine patient acceptance and use of this mHealth application (called MyChemoCare) in a prospective trial of cancer patients (n=60) who are receiving chemotherapy for colorectal cancer at the University of Michigan Comprehensive Cancer Center.
Eligibility Criteria
Inclusion Criteria
- Diagnosed with colon or rectal cancer
- Expected to live at least 6 months
- Initiating chemotherapy for the first time in their treatment history
- Physically and mentally able to participate
- Able to read English
- Willing and able to sign informed consent
Exclusion Criteria
- A treatment plan that does not include cytotoxic chemotherapy for colon or rectal cancer
- A medical history that includes cancer with the exception of in situ cancers of the cervix and basal cell cancers of the skin
- A current diagnosis that includes multiple cancers (this does not exclude metastatic disease)
- Received prior cytotoxic chemotherapy for any reason
- A diagnosed psychiatric disorder
Data sourced from ClinicalTrials.gov (NCT02460822). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.